CLINICAL_TRIALS
trial_result
· 2013-09-02
Clinical Trial Update: A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease [Phase 3]
Summary
A Phase 3 trial of galantamine for mild to moderate Alzheimer's disease was terminated, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Alzheimer's Disease | Phase 3 | Status: TERMINATED | Results posted: 2013-09-02